PortfoliosLab logo
EW vs. IHI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between EW and IHI is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

EW vs. IHI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edwards Lifesciences Corporation (EW) and iShares U.S. Medical Devices ETF (IHI). The values are adjusted to include any dividend payments, if applicable.

600.00%800.00%1,000.00%1,200.00%1,400.00%1,600.00%1,800.00%2,000.00%NovemberDecember2025FebruaryMarchApril
1,958.86%
672.30%
EW
IHI

Key characteristics

Sharpe Ratio

EW:

-0.32

IHI:

0.43

Sortino Ratio

EW:

-0.13

IHI:

0.70

Omega Ratio

EW:

0.97

IHI:

1.10

Calmar Ratio

EW:

-0.25

IHI:

0.43

Martin Ratio

EW:

-0.59

IHI:

1.83

Ulcer Index

EW:

22.52%

IHI:

4.22%

Daily Std Dev

EW:

41.41%

IHI:

18.13%

Max Drawdown

EW:

-54.32%

IHI:

-49.64%

Current Drawdown

EW:

-41.81%

IHI:

-9.83%

Returns By Period

In the year-to-date period, EW achieves a 2.72% return, which is significantly higher than IHI's 2.07% return. Over the past 10 years, EW has outperformed IHI with an annualized return of 13.72%, while IHI has yielded a comparatively lower 12.40% annualized return.


EW

YTD

2.72%

1M

7.23%

6M

9.60%

1Y

-12.02%

5Y*

1.37%

10Y*

13.72%

IHI

YTD

2.07%

1M

0.12%

6M

1.18%

1Y

7.69%

5Y*

7.46%

10Y*

12.40%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EW vs. IHI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EW
The Risk-Adjusted Performance Rank of EW is 3535
Overall Rank
The Sharpe Ratio Rank of EW is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of EW is 3434
Sortino Ratio Rank
The Omega Ratio Rank of EW is 3232
Omega Ratio Rank
The Calmar Ratio Rank of EW is 3737
Calmar Ratio Rank
The Martin Ratio Rank of EW is 4040
Martin Ratio Rank

IHI
The Risk-Adjusted Performance Rank of IHI is 5555
Overall Rank
The Sharpe Ratio Rank of IHI is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of IHI is 5252
Sortino Ratio Rank
The Omega Ratio Rank of IHI is 5353
Omega Ratio Rank
The Calmar Ratio Rank of IHI is 5858
Calmar Ratio Rank
The Martin Ratio Rank of IHI is 5858
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EW vs. IHI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and iShares U.S. Medical Devices ETF (IHI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for EW, currently valued at -0.32, compared to the broader market-2.00-1.000.001.002.003.00
EW: -0.32
IHI: 0.43
The chart of Sortino ratio for EW, currently valued at -0.13, compared to the broader market-6.00-4.00-2.000.002.004.00
EW: -0.13
IHI: 0.70
The chart of Omega ratio for EW, currently valued at 0.97, compared to the broader market0.501.001.502.00
EW: 0.97
IHI: 1.10
The chart of Calmar ratio for EW, currently valued at -0.25, compared to the broader market0.001.002.003.004.005.00
EW: -0.25
IHI: 0.43
The chart of Martin ratio for EW, currently valued at -0.59, compared to the broader market-5.000.005.0010.0015.0020.00
EW: -0.59
IHI: 1.83

The current EW Sharpe Ratio is -0.32, which is lower than the IHI Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of EW and IHI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50NovemberDecember2025FebruaryMarchApril
-0.32
0.43
EW
IHI

Dividends

EW vs. IHI - Dividend Comparison

EW has not paid dividends to shareholders, while IHI's dividend yield for the trailing twelve months is around 0.46%.


TTM20242023202220212020201920182017201620152014
EW
Edwards Lifesciences Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IHI
iShares U.S. Medical Devices ETF
0.46%0.46%0.53%0.45%0.25%0.25%0.33%0.26%0.37%0.55%1.28%0.65%

Drawdowns

EW vs. IHI - Drawdown Comparison

The maximum EW drawdown since its inception was -54.32%, which is greater than IHI's maximum drawdown of -49.64%. Use the drawdown chart below to compare losses from any high point for EW and IHI. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-41.81%
-9.83%
EW
IHI

Volatility

EW vs. IHI - Volatility Comparison

The current volatility for Edwards Lifesciences Corporation (EW) is 11.47%, while iShares U.S. Medical Devices ETF (IHI) has a volatility of 12.10%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than IHI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2025FebruaryMarchApril
11.47%
12.10%
EW
IHI